Skip to main content
Clinical Trials/IRCT201205259855N1
IRCT201205259855N1
Completed
未知

Efficacy of N-Acetyl cystein in prevention of drug induced hepatitis in tuberculosis patient

Overview

Phase
未知
Intervention
Not specified
Conditions
drug induced hepatits.
Sponsor
Arak University of Medical sciences
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • age over 50 years; hemodynamic stability (mean arterial blood pressure \>70 mmHg or systolic blood pressure \>90mmHg ) Exclusion criteria: history of acute or chronic renal and liver failure accordance with the definitions of relevant, Unavailability of information related to liver function in basic mode, use of N\- acetylcysteine orally, injected or inhaled during 1 month before the beginning of the study; Experience has confirmed that the incidence of hypersensitivity reactions following oral, intravenous or inhaled N\- acetylcysteine; receiving concomitant drugs or compounds with antioxidant effects such as vitamin C, vitamin E; HIV \+ patients; use of alcohol

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials